

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | IGF-1R ↓ ↑ | Insulin Receptor ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMS-536924 |
++
IGF-1R, IC50: 100 nM |
+++
Insulin Receptor, IC50: 73 nM |
MEK,FAK | 98% | |||||||||||||||
| GSK1904529A |
+++
IGF-1R, IC50: 27 nM |
+++
Insulin Receptor, IC50: 25 nM |
98+% | ||||||||||||||||
| Picropodophyllin |
++++
IGF-1R, IC50: 1 nM |
99%+ | |||||||||||||||||
| NVP-AEW541 |
++
IGF-1R, IC50: 0.15 μM |
++
Insulin Receptor, IC50: 0.14 μM |
FLT3 | 99%+ | |||||||||||||||
| NVP-ADW742 |
+
IGF-1R, IC50: 0.17 μM |
98% | |||||||||||||||||
| GSK1838705A |
+++
IGF-1R, IC50: 2 nM |
++++
Insulin Receptor, IC50: 1.6 nM |
ALK | 98% | |||||||||||||||
| BMS-754807 |
++++
IGF-1R, IC50: 1.8 nM |
++++
Insulin Receptor, IC50: 1.7 nM |
99%+ | ||||||||||||||||
| Linsitinib |
+++
IGF-1R, IC50: 35 nM |
++
Insulin Receptor, IC50: 75 nM |
99%+ | ||||||||||||||||
| AG1024 |
+
IGF-1R, IC50: 7 μM |
+
Insulin Receptor, IC50: 57 μM |
98% | ||||||||||||||||
| PQ401 |
+
IGF-1R, IC50: <1 μM |
99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | The insulin-like growth factor receptor (IGF-IR) is a transmembrane protein, signaling via the tyrosine kinase domain of which is important for normal cell growth and differentiation. In addition, the IGF-IR stimulates mitogenesis and suppresses apoptosis of cancer cells. PQ401 is a potent inhibitor of IGF-IR signaling which inhibits autophosphorylation of IGF-IR with an IC50 less than 1 μM. PQ401 significantly reduced the proliferation of MCF-7 cells grown in serum with an IC50 of 8 μM. PQ401 also inhibited the growth of MCNeuA cells with an IC50 of 15 μM. PQ401 (15 μM; 24 h) induced caspase-mediated apoptosis. In vivo, PQ401 (50 or 100 mg/kg; i.p.; three times per week) resulted in a significant dose-dependent reduction in tumor growth in female mice model bearing MCNeuA tumor cells[3]. |
| Concentration | Treated Time | Description | References | |
| Cal27 cells | 5 μM | 48 hours | Evaluate the growth inhibitory effect of PQ401 on Cal27 cells, showing that PQ401 alone inhibits cell growth and acts synergistically with gefitinib | Mol Cancer Ther. 2011 Nov;10(11):2124-34. |
| SCC-25 cells | 5 μM | 48 hours | Evaluate the growth inhibitory effect of PQ401 on SCC-25 cells, showing that PQ401 alone inhibits cell growth and acts synergistically with gefitinib | Mol Cancer Ther. 2011 Nov;10(11):2124-34. |
| Enterococcus faecium | 4 μg/ml | PQ401 exhibited antimicrobial activity against E. faecium | mBio. 2020 Jun 30;11(3):e01140-20. | |
| Vancomycin-resistant S. aureus (VRSA) | 4 μg/ml | PQ401 exhibited bactericidal activity against VRSA | mBio. 2020 Jun 30;11(3):e01140-20. | |
| Methicillin-resistant Staphylococcus aureus (MRSA) | 4 μg/ml | 4 hours | PQ401 exhibited bactericidal activity against MRSA, completely killing bacteria within 4 hours | mBio. 2020 Jun 30;11(3):e01140-20. |
| Antler chondrocytes | 10 μM | 24 hours | PQ401 pretreatment significantly attenuated the rIGF1-induced expression of IHH | Cell Cycle. 2017 Mar 19;16(6):522-532. |
| Administration | Dosage | Frequency | Description | References | ||
| Caenorhabditis elegans | MRSA infection model | Liquid medium | 5 μg/ml | 5 days | PQ401 at 5 μg/ml completely prevented C. elegans death caused by MRSA infection | mBio. 2020 Jun 30;11(3):e01140-20. |
| Mice | C57BL/6J mice and NIRKO mice | POA injection | 10 ng | Single injection, monitored for 6 hours | To investigate the inhibitory effect of PQ401 on IGF-1-induced hyperthermia. Results showed that pretreatment with PQ401 significantly attenuated the IGF-1-induced increase in core body temperature and BAT temperature. | J Biol Chem. 2011 Apr 29;286(17):14983-90 |
| Non-obese diabetic (NOD) female mice | Type 1 diabetic mouse model | Intraperitoneal injection | 50 mg/kg | Three times a week for 3 weeks | To investigate the effects of PQ401 on diabetic kidney disease parameters, results showed PQ401 had no significant effects on diabetic state (hyperglycemia, weight loss) or renal disease parameters (hypertrophy, hyperfiltration and albuminuria) | Growth Horm IGF Res. 2011 Oct;21(5):285-91 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.93mL 0.59mL 0.29mL |
14.63mL 2.93mL 1.46mL |
29.26mL 5.85mL 2.93mL |
|
| CAS号 | 196868-63-0 |
| 分子式 | C18H16ClN3O2 |
| 分子量 | 341.79 |
| SMILES Code | O=C(NC1=CC(C)=NC2=CC=CC=C12)NC3=CC(Cl)=CC=C3OC |
| MDL No. | MFCD00160558 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | YBLWOZUPHDKFOT-UHFFFAOYSA-N |
| Pubchem ID | 9549305 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 15 mg/mL(43.89 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1